SMTL ID : 3p2v.1

Novel Benzothiazepine Inhibitor in Complex with human Aldose Reductase

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.69 Å

Oligo State

monomer

Ligands

1 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NAP.1: 33 residues within 4Å: Chain A: G.19, T.20, W.21, K.22, D.44, Y.49, K.78, H.111, W.112, S.160, N.161, Q.184, Y.210, S.211, P.212, L.213, G.214, S.215, P.216, D.217, L.229, A.246, I.261, P.262, K.263, S.264, V.265, T.266, R.269, E.272, N.273, C.299 Ligands: DOY.2 29 PLIP interactions: 29 interactions with chain A Hydrophobic interactions: A:W.21 Hydrogen bonds: A:T.20, A:W.21, A:D.44, A:S.160, A:N.161, A:Q.184, A:S.211, A:L.213, A:S.215, A:S.215, A:D.217, A:D.217, A:K.263, A:S.264, A:V.265, A:T.266, A:N.273, A:N.273 Water bridges: A:D.217, A:A.246, A:K.263, A:R.269, A:R.269 Salt bridges: A:K.22, A:K.263, A:R.269 pi-Stacking: A:Y.210 pi-Cation interactions: A:R.269

2 x DOY: [(2S)-4-oxo-2-phenyl-3,4-dihydro-1,5-benzothiazepin-5(2H)-yl]acetic acid(Non-covalent)

DOY.2: 11 residues within 4Å: Chain A: W.21, V.48, Y.49, W.80, H.111, W.112, F.123, W.220, L.301 Ligands: NAP.1, DOY.3 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:W.80, A:W.112, A:F.123, A:F.123, A:W.220, A:W.220, A:L.301 Hydrogen bonds: A:Y.49 Salt bridges: A:H.111 DOY.3: 8 residues within 4Å: Chain A: F.123, L.125, W.220, A.300, L.301, L.302, S.303 Ligands: DOY.2 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:F.123, A:F.123, A:L.125, A:W.220, A:W.220 Hydrogen bonds: A:L.301, A:L.302, A:S.303 Water bridges: A:A.300, A:A.300

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Koch, C. et al., Ligand-induced fit affects binding modes and provokes changes in crystal packing of aldose reductase. Biochim.Biophys.Acta (2011)

Release Date

2011-08-24

Peptides

Aldose reductase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Aldose reductase

Related Entries With Identical Sequence